FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Titan Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524717 P/E (TTM) :41.23
ISIN Demat:INE150C01011 Div & Yield %:0.19 EPS (TTM) :24.92
Book Value (RS) :189.4317315 Market Cap (Rs Cr.):848.97 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 54.35 39.89 36.25
Other Income 1.32 0.32 312.50
PBIDT 10.65 8.08 31.81
Interest 0.22 0.27 -18.52
PBDT 10.43 7.81 33.55
Depreciation 1.21 1.10 10.00
PBT 9.22 6.71 37.41
Tax 2.86 1.63 75.46
Deferred Tax -0.50 0.08 -725.00
PAT 6.86 5.00 37.20

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)